NovoCure Ltd — Director's Dealing 2020

Dec 23, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2020-12-21

Reporting Person: Benaim Ely (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-21	Ordinary Shares	M	1833	$47.56	Acquired	31189	Direct
2020-12-21	Ordinary Shares	S	1833	$156.71	Disposed	29356	Direct
2020-12-21	Ordinary Shares	M	651	$83.30	Acquired	30007	Direct
2020-12-21	Ordinary Shares	S	651	$156.71	Disposed	29356	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-21	Options to Buy Ordinary Shares	$47.56	M	1833	Disposed	2029-05-07	Ordinary Shares (1833.0)	Direct
2020-12-21	Options to Buy Ordinary Shares	$83.3	M	651	Disposed	2029-07-30	Ordinary Shares (651.0)	Direct

Footnotes

F1: Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim.

F2: Fully vested as of the date hereof.